This midostaurin drug-drug interaction study assessed the dynamic response and clinical usefulness of urinary 6-hydroxycortisol to cortisol ratio ( 6CR ) and plasma 4-hydroxycholesterol ( 4HC ) for monitoring CYP3A4 activity in the presence or absence of rifampicin , a strong CYP3A4 inducer .